Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Amyotroph Lateral Scler Frontotemporal Degener. 2019 Apr 1;20(3-4):216–221. doi: 10.1080/21678421.2019.1582670

Table 2.

Clinician attitudes towards genetic testing

Attitude Item n % Agree % Neutral % Disagree Mean Attitude Score*
Genetic testing should be offered to patients with ALS 66 80.30 12.12 7.58 2.67
Genetic testing should be offered to patients with ALS who have a family history of ALS 67 97.01 2.99 0.00 1.39
Genetic testing can provide useful information to patients with ALS 67 92.54 7.46 0.00 1.93
Genetic testing should be offered to family members of persons with ALS 67 37.31 29.85 32.84 1.93
Genetic testing should be offered to family members of persons with ALS who have a gene mutation 66 68.18 18.18 13.64 3.15
Genetic testing can provide useful information to family members of person with ALS 65 72.31 20.00 7.69 3.15
If I had ALS and were offered genetic testing, I would have testing 67 62.69 22.39 14.93 3.24
Genetic testing can help researchers/clinicians understand ALS 67 97.01 1.49 1.49 1.42
In the future, genetic testing may help researchers/clinicians 66 98.48 1.52 0.00 1.30
Average:2.23
*

Attitude score was calculated for each respondent by assigning a numeric value to each Likert response, with a possible range of 0 to 10, with 0 being the most positive and 5 representing a neutral attitude.